![Nanoparticle-mediated synergistic chemoimmunotherapy for tailoring cancer therapy: recent advances and perspectives | Journal of Nanobiotechnology | Full Text Nanoparticle-mediated synergistic chemoimmunotherapy for tailoring cancer therapy: recent advances and perspectives | Journal of Nanobiotechnology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12951-021-00861-0/MediaObjects/12951_2021_861_Fig2_HTML.png)
Nanoparticle-mediated synergistic chemoimmunotherapy for tailoring cancer therapy: recent advances and perspectives | Journal of Nanobiotechnology | Full Text
![Nanoparticle-mediated synergistic chemoimmunotherapy for tailoring cancer therapy: recent advances and perspectives | Journal of Nanobiotechnology | Full Text Nanoparticle-mediated synergistic chemoimmunotherapy for tailoring cancer therapy: recent advances and perspectives | Journal of Nanobiotechnology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12951-021-00861-0/MediaObjects/12951_2021_861_Fig3_HTML.png)
Nanoparticle-mediated synergistic chemoimmunotherapy for tailoring cancer therapy: recent advances and perspectives | Journal of Nanobiotechnology | Full Text
![Reports on toxicokinetics, toxicity and allergenicity data on substances to be evaluated as acceptable previous cargoes for edible fats and oils (NP/EFSA/CONTAM/2011/01) – Batches n. 1, 2 and 3 - Bassan - Reports on toxicokinetics, toxicity and allergenicity data on substances to be evaluated as acceptable previous cargoes for edible fats and oils (NP/EFSA/CONTAM/2011/01) – Batches n. 1, 2 and 3 - Bassan -](https://efsa.onlinelibrary.wiley.com/cms/asset/096b7ca6-d71b-4c17-a35c-04f7cf11078a/efs3.2012.9.issue-12.cover.jpg?trick=1673652227383)